Correspondence 0001683168-23-007352 from Sonoma Pharmaceuticals, Inc. (SNOA)
Sonoma Pharmaceuticals, Inc.
Date: Oct. 24, 2023 · CIK: 0001367083 · Accession: 0001683168-23-007352
AI Filing Summary & Sentiment
File numbers found in text: 333-274582
Show Raw Text
CORRESP
1
filename1.htm
October 24, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attn: Cindy Polynice, Jason Drory
Re:
Sonoma Pharmaceuticals, Inc.
Registration Statement on Form S-1
Filed September 19, 2023, as amended
File No. 333-274582
Acceleration Request
Requested Date: October 25, 2023
Requested Time: 5:00 P.M. Eastern Standard Time
Dear Ms. Polynice:
Pursuant to Rule 461 of the Rules and Regulations
promulgated under the Securities Act of 1933, as amended, Sonoma Pharmaceuticals, Inc. (the “Company”), hereby requests that
the above-captioned Registration Statement on Form S-1, as amended, (the “Registration Statement”) be accelerated to October
25, 2023 at 5:00 pm EST or as soon as practicable thereafter.
The cooperation of the staff in meeting the Company’s
request is very much appreciated. Please contact me if you have any questions or if we can otherwise be of assistance to you.
Sincerely,
/s/ Amy Trombly
Amy Trombly, Esq.